Fritextsökning
Artiklar per år
Innehållstyper
-
ALS – When the body has given up, but the brain persists
The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and with the help of, among other things, a Swedish-developed invention, communication with the outside world can continue. “It’s their window to the world,” says ALS researcher Caroline Ingre.
-
She creates pharmaceuticals on a 3D printer
The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a well-advanced project with 3D-printed drugs at Uppsala University. “It will soon be available in clinics”, says Christel Bergström, who is heading the project.
-
Fritt fram för desinformation om covid-19 på Twitter
Yttrandefrihet ska råda på Twitter, enligt nya ägaren Elon Musk, och nu har regler för att förhindra spridning av desinformation om covid-19 tagits bort.
-
ALS – När kroppen har gett upp men hjärnan finns kvar
Nervsjukdomen ALS berövar patienten gradvis kontrollen över musklerna, och till sist även talet. Men ögonen fortsätter att fungera, och med hjälp av bland annat en svenskutvecklad uppfinning kan kommunikationen med omvärlden fortsätta. "Det är deras fönster mot världen", säger ALS-forskaren Caroline Ingre.
-
Neanderthal genes and Nobel Prize in a popular lecture at Bioscience
An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter of time before we actively start screening for it,” said KI researcher Hugo Zeberg when describing the study at Bioscience 2022.
-
Karriärcoachen: Byta jobb i lågkonjunktur – det här ska du tänka på
Ekonomiska tyckare varnar för att Sverige är på väg in i en lågkonjunktur. Krig i Ukraina, rusande elpriser, hög inflation och höjd styrränta är bara några av anledningarna till att tänka två gånger om du har planer på att byta jobb. Karriärcoachen Tina Persson tipsar om vad du bör tänka på.
-
She is Sweden´s new Minister of Healthcare
Today, Tuesday, Swedish Prime Minister Ulf Kristersson, who leads the Moderate Party and the centre-right coalition in Sweden, presented the government's new ministers. Christian Democrat Jakob Forssmed gets the role of Minister for Social Affairs
-
Cytel Inc acquires the SDS Group
The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consulting company SDS Life Science.
-
Brown Dog Affair: Djurförsöket som skakade Storbritannien
En intet ont anande terrier, två svenska djurrättsaktivister, en känd fysiolog, brittiska medicinstudenter och en staty som behövde polisskydd. Det är några av ingredienserna i "Brown Dog affair" – en konflikt om djurförsök som splittrade England i början av 1900-talet.
-
“We aim to be a start-up company with an academic spirit”
Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working on developing drugs for both conditions.
-
“We need to keep investing in research and innovation”
Jenni Nordborg has worked for just over four years to highlight life science in Sweden. Her mandate as national coordinator ends in December 2022. ““Life sciences has been a long-term priority of governments since many years and I have no doubt that the ambitions will be strong going forward”, says Jenni Nordborg.
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely expensive treatments with biological drugs. So, how well has Swedish healthcare used biosimilars? The answer partly depends on whom you ask.
-
Business Sweden’s new team is rolling out the blue-yellow carpet
According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sweden. “It’s a perfect storm, a beneficent, perfect storm,” says Programme Manager Britta Stenson.
-
FOKUS Patient turns international
FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.
-
Bought a tablet factory – and built his own empire
In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move its production abroad. 34-year-old Thomas was facing an imminent risk of losing his job. However, instead, it actually turned out to be the starting point for one of the biggest success stories in Swedish life science.
-
Swedish-Danish meeting at Medicon Village: “One of the most important life science congresses”
For the eleventh year, The Future of Swedish and Danish Life Science was held on Wednesday, and the event continues to function as a connecting link between the life science sectors of both countries. This year’s event attracted nearly 450 visitors.
-
Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"
The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – a decision that has been growing for some time. “I have been pretty much married to my mission. However, I will turn 56 this autumn, and if I’m going to do something else in my professional life, now is the time,” he says.
-
Lucy Robertshaw: Did you know Stockholm wants to be in top 5 in the world for Life Sciences?
Karolinska Institutet Solna Campus has certainly become the next “Kendall Square”, writes Lucy Robertshaw in a column.
-
Sweden is heavily criticised for not ordering Covid vaccine
Valneva and the EU Commission have entered into an agreement for 1.25 million doses of the company’s Covid vaccine, but Sweden has not placed an order.
-
Britta Björkholm blir SBU:s nya generaldirektör
Regeringen har utsett Britta Björkholm till ny generaldirektör för Statens beredning för medicinsk och social utvärdering, SBU.
-
Study: Our behaviour may have been guided by wishful thinking during the pandemic
A new study suggests that we systematically underestimate health risks if and when it suits us. This was especially true during the pandemic, as our risk assessments may have been guided by wishful thinking rather than a rational perception of the risks.
-
Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”
“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportunities,” Björn Arvidsson writes in a column.
-
FHM vill narkotikaklassa åtta substanser
Folkhälsomyndigheten vill att ytterligare åtta psykoaktiva substanser ska klassas som narkotika.
-
Marie Gårdmark: New incentives for orphan products on its way
"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave for drug development in a broader context", writes Marie Gårdmark in a column.
BREAKING